APA (7th ed.) Citation

M, L., V, L. G., G, G., N, M., N, A., C, M., . . . N, C. (2022). Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus: The French GR2 study. Rheumatology (Oxford, England), 61(9), 3657. https://doi.org/10.1093/rheumatology/keab943

Chicago Style (17th ed.) Citation

M, Larosa, et al. "Evaluation of Lupus Anticoagulant, Damage, and Remission as Predictors of Pregnancy Complications in Systemic Lupus Erythematosus: The French GR2 Study." Rheumatology (Oxford, England) 61, no. 9 (2022): 3657. https://doi.org/10.1093/rheumatology/keab943.

MLA (9th ed.) Citation

M, Larosa, et al. "Evaluation of Lupus Anticoagulant, Damage, and Remission as Predictors of Pregnancy Complications in Systemic Lupus Erythematosus: The French GR2 Study." Rheumatology (Oxford, England), vol. 61, no. 9, 2022, p. 3657, https://doi.org/10.1093/rheumatology/keab943.